Notably, steroid hormone signaling does not act in isolation but rather is integrated with several key oncogenic pathways in NSCLC, such as EGFR, PI3K/AKT, MAPK, and STAT3. This evidence concerns the gene STAT3 and non-small cell lung carcinoma.